Cornwall James W, Han Daniel K, Fremed Daniel I, Faries Peter L, Vouyouka Ageliki G
Division of Vascular Surgery, Department of Surgery, Mount Sinai Medical Center, New York, NY.
J Vasc Surg Cases Innov Tech. 2017 Mar 6;3(1):37-40. doi: 10.1016/j.jvscit.2016.11.001. eCollection 2017 Mar.
Endovascular repair of iliac artery aneurysms has emerged as an alternative to traditional open surgical repair. Although there is little consensus on indications to preserve hypogastric blood flow during aneurysm repair, it is well understood that complications from bilateral hypogastric occlusion may be significant. The GORE EXCLUDER Iliac Branch Endoprosthesis (W. L. Gore and Associates, Flagstaff, Ariz) received United States Food and Drug Administration approval in March 2016 for treatment of common iliac artery and aortoiliac aneurysms. This case report discusses an off-label use of GORE EXCLUDER Iliac Branch Endoprosthesis to maintain pelvic perfusion during treatment of bilateral internal iliac artery aneurysms without surrounding aortoiliac pathology.
髂动脉瘤的血管内修复已成为传统开放手术修复的替代方法。尽管在动脉瘤修复过程中保留髂内血流的指征方面几乎没有共识，但人们清楚地知道双侧髂内动脉闭塞的并发症可能很严重。GORE EXCLUDER髂支血管内支架（美国亚利桑那州弗拉格斯塔夫的W. L. 戈尔公司）于2016年3月获得美国食品药品监督管理局批准，用于治疗髂总动脉和主髂动脉瘤。本病例报告讨论了GORE EXCLUDER髂支血管内支架在治疗双侧髂内动脉瘤且无周围主髂病变时维持盆腔灌注的非标签使用情况。
